JP2022518496A5 - - Google Patents
Info
- Publication number
- JP2022518496A5 JP2022518496A5 JP2021542366A JP2021542366A JP2022518496A5 JP 2022518496 A5 JP2022518496 A5 JP 2022518496A5 JP 2021542366 A JP2021542366 A JP 2021542366A JP 2021542366 A JP2021542366 A JP 2021542366A JP 2022518496 A5 JP2022518496 A5 JP 2022518496A5
- Authority
- JP
- Japan
- Prior art keywords
- plasminogen
- patient
- pharmaceutical composition
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19153572.3 | 2019-01-24 | ||
| EP19153572 | 2019-01-24 | ||
| PCT/EP2020/051733 WO2020152322A1 (en) | 2019-01-24 | 2020-01-24 | Plasminogen for treating and preventing microthrombosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022518496A JP2022518496A (ja) | 2022-03-15 |
| JP2022518496A5 true JP2022518496A5 (https=) | 2023-01-31 |
Family
ID=65234430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542366A Pending JP2022518496A (ja) | 2019-01-24 | 2020-01-24 | 微小血栓症を処置及び予防するためのプラスミノーゲン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220072110A1 (https=) |
| EP (1) | EP3914288A1 (https=) |
| JP (1) | JP2022518496A (https=) |
| KR (1) | KR20210119428A (https=) |
| CN (1) | CN113597313A (https=) |
| AU (1) | AU2020212404B2 (https=) |
| BR (1) | BR112021014068A2 (https=) |
| CA (1) | CA3127375A1 (https=) |
| WO (1) | WO2020152322A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022258590A1 (en) | 2021-06-08 | 2022-12-15 | Previpharma Consulting Gmbh | Process for isolating plasminogen from a blood plasma fraction |
| WO2025132796A1 (en) | 2023-12-21 | 2025-06-26 | Previpharma Consulting Gmbh | Process for isolating glu-plasminogen from a solution |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2254316B1 (https=) * | 1973-12-18 | 1977-04-22 | Choay Sa | |
| US5520912A (en) | 1993-07-02 | 1996-05-28 | Immuno Aktiengesellschaft | Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen |
| TWI801331B (zh) * | 2015-11-03 | 2023-05-11 | 美商波麥堤克生物治療股份有限公司 | 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法 |
| ES2982294T3 (es) * | 2015-12-18 | 2024-10-15 | Talengen Int Ltd | Plasminógeno para su uso en el tratamiento o prevención de lesiones nerviosas por diabetes mellitus |
| ES2968254T3 (es) * | 2015-12-18 | 2024-05-08 | Talengen Int Ltd | Plasminógeno para su uso en la prevención o el tratamiento de la trombosis aguda y la trombosis crónica |
| DK3391902T5 (da) * | 2015-12-18 | 2024-09-23 | Talengen Int Ltd | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati |
| KR102640024B1 (ko) * | 2017-03-09 | 2024-02-22 | 프리비파하르마, 컨설팅 게엠베하 | 혈액 분획으로부터의 Glu-플라스미노겐의 제조 및 용도 |
-
2020
- 2020-01-24 AU AU2020212404A patent/AU2020212404B2/en active Active
- 2020-01-24 KR KR1020217025524A patent/KR20210119428A/ko not_active Ceased
- 2020-01-24 JP JP2021542366A patent/JP2022518496A/ja active Pending
- 2020-01-24 CA CA3127375A patent/CA3127375A1/en active Pending
- 2020-01-24 US US17/422,962 patent/US20220072110A1/en active Pending
- 2020-01-24 BR BR112021014068-9A patent/BR112021014068A2/pt unknown
- 2020-01-24 EP EP20703164.2A patent/EP3914288A1/en active Pending
- 2020-01-24 CN CN202080021518.7A patent/CN113597313A/zh active Pending
- 2020-01-24 WO PCT/EP2020/051733 patent/WO2020152322A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Richard et al. | Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator | |
| Schmidt et al. | Microcatheter urokinase infusion in central retinal artery occlusion | |
| Westrick et al. | Plasminogen activator inhibitor-1 in vascular thrombosis | |
| JP2784146B2 (ja) | ｌｙｓ−プラスミノーゲンを含有する虚血性事象及び再灌流損傷の予防・治療剤 | |
| US11147859B2 (en) | Diffusion enhancing compounds and their use alone or with thrombolytics | |
| Herderschee et al. | Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF‐SPECT | |
| JP6914957B2 (ja) | 脳卒中の処置における使用のためのイマチニブ | |
| JP2022518496A5 (https=) | ||
| Martin et al. | Short-term ultrahigh streptokinase treatment of chronic arterial occlusions and acute deep vein thromboses | |
| Xu | Efficacy of different doses of alteplase thrombolysis on acute ischemic stroke in patients. | |
| Del-Rio Camacho et al. | Moyamoya disease and sagittal sinus thrombosis in a child with Down's syndrome | |
| Herderschee et al. | Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. | |
| Yalcin-Cakmakli et al. | Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion | |
| Sagripanti et al. | Iloprost in the treatment of thrombotic microangiopathy: report of thirteen cases | |
| RU2021124857A (ru) | Плазминоген для лечения и профилактики микротромбоза | |
| JPH10502652A (ja) | 一時的な局在性虚血により惹起される再灌流障害の処置のための、（Ｓ）−アダマンチル−Ｌ−メチオニン（ＳＡＭｅ）及びその生理学的に認容性の塩の使用 | |
| KUWAHARA et al. | Superior Sagittal Sinus and Cerebral Cortical Venous Thrombosis Caused by Congenital Protein C Deficiency—Case Report— | |
| Liu‐DeRyke et al. | Hemostatic therapy for the treatment of intracranial hemorrhage | |
| Worthley et al. | Acute haemorrhagic stroke | |
| CN116782911A (zh) | 治疗性化合物、组合物及其使用方法 | |
| Ogawa et al. | Multidisciplinary Treatment for Multiple Dural Arteriovenous Fistulas/Arteriovenous Malformation Associated with Congenital Protein S Deficiency: A Case Report and Literature Review | |
| IL301410A (en) | FACTOR XIa OR KALLIKREIN INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE THEREOF | |
| JP | PATHOPHYSIOLOGY AND MANAGEMENT OF BRAIN INFARCTION | |
| WO2007013842A1 (en) | Use of 4-((tert-butylimino)methyl) benzene-1,3-disulfonate n-oxide against maemorrhagic changes in the brain | |
| Greven et al. | Albert & Jakobiec's Principles & Practice of Ophthalmology |